Reports
Sale
Global Cardiopulmonary Bypass Equipment Market Size, Share, Growth, Analysis, Report: By Type: Single Roller Pump, Double Roller Pump; By End User: Hospitals, Ambulatory Surgical Centres; Market Dynamics; Regional Analysis; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Funding and Investment Analysis; Supplier Landscape; 2024-2032
Global Cardiopulmonary Bypass Equipment Market Outlook
The global cardiopulmonary bypass equipment market size attained a value of 285.5 million in 2023. The market is expected to grow at a CAGR of 4.0% between 2024 and 2032, reaching almost 406.4 million by 2032.
Cardiopulmonary Bypass Equipment: Introduction
Cardiopulmonary bypass equipment, also known as on the pump or heart-lung machine, inhibits blood flow towards the heart and lungs at the time of a surgery. It empties the heart and stops it from beating so that the surgeons can work on it efficiently. In addition, it also helps in removing carbon dioxide and oxygenating blood.
A cardiopulmonary bypass machine consists of cannulas, reservoir container, pump, and oxygenator. It can provide several benefits like preventing blood loss and swelling during surgery, making the heart still so that the surgeons can operate on the heart effectively and protects the cardiac muscle tissue.
Global Cardiopulmonary Bypass Equipment Market Analysis
Cardiopulmonary bypass (CPB) technology is widely used in bypass coronary arteries, repairing, and replacing heart valves, treating aortic pathologies and even heart transplants. With the incidence of cardiac surgeries, the cardiopulmonary bypass equipment market value has experienced a considerable growth.
As there is a prevalence towards minimally invasive surgeries, there has been a change in the standard CPB circuits. Conventionally it used to be a closed circuit, however, to avoid mass bleeding during re-transfusion, it has been changed to open circuits. Similarly, bubble oxygenators have now evolved to membrane oxygenators and there has been a shift from traditional rollers to centrifugal pumps. Therefore, there has been continuous research and innovation to improve the existing technologies with a vision to bring better treatment options for the patients.
In April 2024, LivaNova launched Essenz Heart Lung Machine (HLM), to support open-heart surgeries in adult as well as paediatric patients. It comes with a personalized perfusion approach that allows accurate sensing for data driven decision making. It has also gained FDA approval. Essenz HLM utilises contemporary technologies that provide accuracy and efficacy in the procedure. For instance, it offers better visibility with an intuitive graphic user interface. It also integrates cybersecurity provisions to safeguard a patients’ data. Such technical advancements indicate that cardiopulmonary bypass equipment market growth is definite in the future as well.
Global Cardiopulmonary Bypass Equipment Market Segmentation
Market Breakup by Type
- Single Roller Pump
- Double Roller Pump
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cardiopulmonary Bypass Equipment Market Overview
Every year, around 2 million people undergo open heart surgeries to treat various cardiac problems. Owing to the high incidence of cardiac diseases and an aging population, the North American region has held majority of the cardiopulmonary bypass equipment market share. The presence of key healthcare players in the United States along with a strong infrastructure to support technology driven equipment has led to the considerable market size.
The Asia Pacific market size is expected to grow fastest owing to the rising geriatric population and chronic diseases associated with it. There has been critical emphasis on educating the masses with relevant information revolving around cardiac health. Moreover, with the easy availability of resources and the government inviting foreign capital investments, a proficient research and technology supported infrastructure will create significant value to fuel market growth in the future.
Global Cardiopulmonary Bypass Equipment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic
- LivaNova Plc
- MAQUET Holding
- Abiomed
- Brail Biomedica
- Tianjin Medica
- Terumo Corp
- Senko Medical Instrument Manufacturing Co.
- Technowood Corp
- Sorin
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cardiopulmonary Bypass Equipment Market Overview
3.1 Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023)
3.2 Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4 Global Cardiopulmonary Bypass Equipment Market Landscape
4.1 Global Cardiopulmonary Bypass Equipment: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiopulmonary Bypass Equipment: Product Landscape
4.2.1 Analysis by Method
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Cardiopulmonary Bypass Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cardiopulmonary Bypass Equipment Market Segmentation
6.1 Global Cardiopulmonary Bypass Equipment Market by Type
6.1.1 Market Overview
6.1.2 Single Roller Pump
6.1.3 Double Roller Pump
6.2 Global Cardiopulmonary Bypass Equipment Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centres
6.3 Global Cardiopulmonary Bypass Equipment Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Cardiopulmonary Bypass Equipment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiopulmonary Bypass Equipment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiopulmonary Bypass Equipment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cardiopulmonary Bypass Equipment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiopulmonary Bypass Equipment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Medtronic
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 LivaNova Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 MAQUET Holding
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Abiomed
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Brail Biomedica
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Tianjin Medica
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Terumo Corp
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Senko Medical Instrument Manufacturing Co.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Technowood Corp
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Sorin
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 285.5 million in 2023, driven by the increasing volume of cardiovascular diseases in the aging population and extensive research and innovations in healthcare industry.
The market is anticipated to grow at a CAGR of 4% during the forecast period of 2024-2032, likely to reach a market value of USD 406.4 million by 2032.
The market demand has grown with the incidence of cardiovascular diseases and increased awareness on cardiovascular health by government.
The current market scenario involves the preference of minimally invasive techniques for any surgery followed by the adoption of digital and artificial intelligence driven techniques to make the procedure accurate and avoid any post-surgical complications.
Single and double roller pumps are used in cardiopulmonary bypass equipment.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The end users in the market include hospitals and ambulatory surgical centres.
Key players involved in the market are Medtronic, LivaNova Plc, MAQUET Holding, Abiomed, Brail Biomedica, Tianjin Medica, Terumo Corp, Senko Medical Instrument Manufacturing Co., Technowood Corp, and Sorin.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER